Response rates after 4 cycles of PCD treatment and time to response in group A versus group B
| Response . | Group A(n = 48) . | Group B(n = 49) . | P . |
|---|---|---|---|
| Complete remission | 1 (2) | 0 (0) | |
| Very good PR | 16 (33) | 16 (33) | |
| PR | 24 (50) | 25 (51) | |
| Stable disease | 2 (4) | 1 (2) | |
| Progressive disease | 2 (4) | 4 (8) | |
| Response failure | 3 (6) | 3 (6) | |
| Partial remission or better | 41 (85) | 41 (84) | 1 |
| Time to response (≥PR), d (IQR) | 28 (27-56) | 28(27-55) | .71 |
| Response . | Group A(n = 48) . | Group B(n = 49) . | P . |
|---|---|---|---|
| Complete remission | 1 (2) | 0 (0) | |
| Very good PR | 16 (33) | 16 (33) | |
| PR | 24 (50) | 25 (51) | |
| Stable disease | 2 (4) | 1 (2) | |
| Progressive disease | 2 (4) | 4 (8) | |
| Response failure | 3 (6) | 3 (6) | |
| Partial remission or better | 41 (85) | 41 (84) | 1 |
| Time to response (≥PR), d (IQR) | 28 (27-56) | 28(27-55) | .71 |
Values shown are n (%), unless stated otherwise. Group A: relapsing patients without previous ASCT (from arm A of IFM 2009 trial), Group B: relapsing patients with a previous ASCT (from arm B of IFM 2009 trial).